Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2012, Article ID 810156, 12 pages
http://dx.doi.org/10.1155/2012/810156
Research Article

Sensitive Spectrophotometric Determination of Atenolol in Pharmaceutical Formulations Using Bromate-Bromide Mixture as an Eco-Friendly Brominating Agent

Department of Chemistry, University of Mysore, Manasagangotri, Mysore 570006, Karnataka, India

Received 25 November 2011; Accepted 27 December 2011

Academic Editor: Dario Compagnone

Copyright © 2012 Kudige N. Prashanth and Kanakapura Basavaiah. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, Merck & Co., Whitehouse Station, NJ, USA, 11th edition, 1989.
  2. R. N. Hegde, B. E. Kumara Swamy, B. S. Sherigara, and Nandibewoor S. T., “Electro-oxidation of atenolol at a glassy carbon electrode,” International Journal of Electrochemical Science, vol. 3, no. 3, pp. 302–314, 2008. View at Google Scholar
  3. Indian Pharmacopoeia, Ministry of Health and Family Welfare, Government of India, New Delhi, India, 4th edition, 1996.
  4. British Pharmacopoeia, vol. I, Her Majesty's Stationary Office, London, UK, 1988.
  5. M. A. Gotardo, R. Sequinel, L. Pezza, and H. R. Pezza, “Determination of atenolol in pharmaceutical formulations by diffuse reflectance spectroscopy,” Ecletica Quimica, vol. 33, no. 4, pp. 7–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Modamio, C. F. Lastra, and E. L. Marino, “Error structure for the HPLC analysis for atenolol, metoprolol and propranolol: a useful weighting method in parameter estimation,” Journal of Pharmaceutical and Biomedical Analysis, vol. 17, no. 3, pp. 507–513, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. S. S. Zarapkar, S. S. Kolte, and S. H. Rane, “High performance liquid chromatographic determination of amlodipine and atenolol, simultaneously from pharmaceutical preparation,” Indian Drugs, vol. 34, no. 6, pp. 350–353, 1997. View at Google Scholar · View at Scopus
  8. S. V. Erram and H. P. Tipnis, “Simultaneous determination of atenolol and nifedipine in solid dosage forms by RP [reversed-phase] HPLC,” Indian Drugs, vol. 29, no. 10, pp. 436–438, 1992. View at Google Scholar · View at Scopus
  9. R. Jain and C. L. Jain, “Simultaneous microquantification of nifedipine and atenolol in multicomponent dosage forms using high performance liquid chromatography,” Microchemical Journal, vol. 44, no. 2, pp. 187–192, 1991. View at Google Scholar · View at Scopus
  10. D. Radulovic, L. J. Zivanovic, and G. Velimirovic, “High-performance liquid-chromatographic determination of atenolol in tablets,” Analytical Letters, vol. 24, no. 10, pp. 1813–1823, 1991. View at Google Scholar
  11. R. T. Sane, V. R. Bhate, V. G. Nayak, and K. D. Ladge, “Simultaneous determination of atenolol, hydrochlorthiazide and amiloride hydrochloride frome marketed preparation by reversed-phase high performance liquid chromatography,” Indian Drugs, vol. 28, no. 7, pp. 322–325, 1991. View at Google Scholar · View at Scopus
  12. Z. Pawlak and B. J. Clark, “The assay and resolution of the beta-blocker atenolol from its related impurities in a tablet pharmaceutical dosage form,” Journal of Pharmaceutical and Biomedical Analysis, vol. 10, no. 5, pp. 329–334, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Gong, “High-performance liquid-chromatographic determination of atenolol in compound tablets,” Yaowu Fenxi Zazhi, vol. 9, pp. 175–176, 1989. View at Google Scholar
  14. S. I. Sa'sa, I. M. Jalal, and H. S. Khalil, “Determination of atenolol combinations with hydrochlorothiazide and chlorthalidone in tablet formulations by reverse-phase HPLC,” Journal of Liquid Chromatography and Related Technologies, vol. 11, no. 8, pp. 1673–1696, 1988. View at Google Scholar
  15. R. Ficarra, P. Ficarra, A. Tommasini, M. L. Calabro, and C. Guarniera-Fenech, “HPLC determination of atenolol and chlorthalidone present together in pharmaceutical preparations,” Farmaco-Edizione Pratica, vol. 40, no. 9, pp. 307–312, 1985. View at Google Scholar
  16. I. Rapado-Martinez, M. C. Garcia-Alvarez-Coque, and R. M. Villanueva-Camanas, “Liquid chromatographic procedure for the evaluation of β-blockers in pharmaceuticals using hybrid micellar mobile phases,” Journal of Chromatography A, vol. 765, no. 2, pp. 221–231, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. M. I. R. M. Santoro, H. S. Cho, and E. R. M. Kedor-Hackmann, “Enantiomeric separation and quantitative determination of atenolol in tablets by chiral high-performance liquid chromatography,” Drug Development and Industrial Pharmacy, vol. 26, no. 10, pp. 1107–1110, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Ceresole, M. A. Moyano, M. T. Pizzorno, and A. I. Segall, “Validated reversed-phase HPLC method for the determination of atenolol in the presence of its major degradation product,” Journal of Liquid Chromatography and Related Technologies, vol. 29, no. 20, pp. 3009–3019, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Bing, D. F. Hu, and F. Liu, “HPLC determination of atenolol and nifedipine in compound atenolol tablets,” Yaowu Fenxi Zazhi, vol. 24, no. 5, pp. 485–486, 2004. View at Google Scholar
  20. A. K. Singh, E. R. M. Kedor-Hackmann, and M. I. R. M. Santoro, “Development and validation of a chiral liquid chromatographic method for the determination of atenolol and metoprolol enantiomers in tablet preparations,” Journal of AOAC International, vol. 84, no. 6, pp. 1724–1729, 2001. View at Google Scholar · View at Scopus
  21. R. Bhushan and S. Tanwar, “Reversed-phase high-performance liquid chromatographic enantioresolution of six β-blockers using dinitrophenyl-L-Pro-N-hydroxysuccinimide ester, N-succinimidyl-(S)-2-(6-methoxynaphth-2-yl) propionate and twelve variants of Sanger's reagent as chiral derivatizing reagents,” Biomedical Chromatography, vol. 23, no. 12, pp. 1291–1299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. K. Barman, M. A. U. Islam, M. Ahmed et al., “Simultaneous high-performance liquid chromatographic determination of atenolol and amlodipine in pharmaceutical-dosage form,” Pakistan Journal of Pharmaceutical Sciences, vol. 20, no. 4, pp. 274–279, 2007. View at Google Scholar · View at Scopus
  23. A. Holbrook, A. M. Krstulovic, J. H. Miller, and J. Rysaluk, “Limitation of impurities in atenolol by liquid chromatography,” Pharmeuropa, vol. 3, no. 3, pp. 218–225, 1991. View at Google Scholar
  24. R. Mehvar, “Stereospecific liquid chromatographic analysis of racemic adrenergic drugs utilizing precolumn derivatization with (–)menthyl chloroformate,” Journal of Chromatography B, vol. 493, no. 2, pp. 402–408, 1989. View at Publisher · View at Google Scholar · View at Scopus
  25. P. P. Vazquez, M. M. Galera, A. S. Guirado, and M. M. P. Vazquez, “Determination of five beta-blockers in wastewaters by coupled-column liquid chromatography and fluorescence detection,” Analytica Chimica Acta, vol. 666, no. 1-2, pp. 38–44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. S. El Deeb, “Evaluation of a vancomycin-based LC column in enantiomeric separation of atenolol: method development, repeatability study and enantiomeric impurity determination,” Chromatographia, vol. 71, no. 9-10, pp. 783–787, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. P. Argekar and S. G. Powar, “Simultaneous determination of atenolol and amlodipine in tablets by high-performance thin-layer chromatography,” Journal of Pharmaceutical and Biomedical Analysis, vol. 21, no. 6, pp. 1137–1142, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. A. P. Argekar and J. G. Sawant, “Simultaneous determination of atenolol and nitrendipine in pharmaceutical dosage forms by HPTLC,” Journal of Liquid Chromatography and Related Technologies, vol. 22, no. 10, pp. 1571–1578, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. D. D. Rao, N. V. Satyanarayana, S. S. Sait, Y. R. Reddy, and K. Mukkanti, “Simultaneous determination of losartan potassium, atenolol and hydrochlorothiazide in pharmaceutical preparations by stability-indicating UPLC,” Chromatographia, vol. 70, no. 3-4, pp. 647–651, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. G. S. Sadana and A. B. Ghogare, “Quantitative gas liquid chromatographic determination of atenolol in bulk drug and pharmaceutical preparations,” Indian Drugs, vol. 28, no. 3, pp. 142–145, 1990. View at Google Scholar · View at Scopus
  31. G. R. Rao, A. B. Avadhanulu, R. Giridhar, A. R. R. Pantulu, and C. K. Kokate, “Estimation of atenolol and nifedipine in single and combined dosage forms by GLC,” Eastern Pharmacist, vol. 33, no. 386, pp. 113–115, 1990. View at Google Scholar
  32. R. Ghanem, M. A. Bello, M. Callejon, and A. Guirafim, “Determination of beta-blocker drugs in pharmaceutical preparations by non-suppressed ion chromatography,” Journal of Pharmaceutical and Biomedical Analysis, vol. 15, no. 3, pp. 383–388, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. H. C. Zhao, N. H. Yan, and J. X. Guo, “Rapid determination of atenolol in tablets by flow-injection fluorimetry,” Fenxi Shiyanshi, vol. 13, no. 5, pp. 36–38, 1994. View at Google Scholar
  34. M. Gajewska, G. Glass, and J. Kostelecki, “Spectrofluorimetric determination of propranolol and atenolol,” Acta Poloniae Pharmaceutica, vol. 49, no. 3, pp. 1–4, 1992. View at Google Scholar
  35. G. Pyramides, J. W. Robinson, and S. W. Zito, “The combined use of DSC and TGA for the thermal analysis of atenolol tablets,” Journal of Pharmaceutical and Biomedical Analysis, vol. 13, no. 2, pp. 103–110, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. K. A. Azzam, A. A. Elbashir, M. A. Elbashir, B. Saad, and S. A. Hamid, “Simultaneous determination of atenolol and chlorthalidone in pharmaceutical preparations by capillary-zone electrophoresis,” Analytical Letters, vol. 42, no. 10, pp. 1458–1470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Shafaati and B. J. Clark, “Development and validation of a capillary zone electrophoretic method for the determination of atenolol in presence of its related substances in bulk and tablet dosage form,” Journal of Pharmaceutical and Biomedical Analysis, vol. 14, no. 11, pp. 1547–1554, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. X. W. Zhou, J. Q. Lv, and Z. R. Zeng, “Determination of atenolol by capillary electrophoresis electrogenerated chemiluminescence,” Fenxi Kexue Xuebao, vol. 23, no. 1, pp. 30–32, 2007. View at Google Scholar
  39. R. N. Goyal and S. P. Singh, “Voltammetric determination of atenolol at C60-modified glassy carbon electrodes,” Talanta, vol. 69, no. 4, pp. 932–937, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Shamsipur, F. Jalali, and S. Haghgoo, “Preparation of an atenolol ion-selective electrode and its application to pharmaceutical analysis,” Analytical Letters, vol. 38, no. 3, pp. 401–410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. M. A. El Ries, “Indirect atomic absorption spectrometric (AAS) determination of atenolol,” Analytical Letters, vol. 28, no. 9, pp. 1629–1639, 1995. View at Google Scholar
  42. C. V. N. Prasad, C. Parihar, K. Sunil, and P. Parimoo, “Simultaneous determination of amiloride HCl, hydrochlorothiazide and atenolol in combined formulations by derivative spectroscopy,” Journal of Pharmaceutical and Biomedical Analysis, vol. 17, no. 4-5, pp. 877–884, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. C. V. N. Prasad, C. Parihar, T. R. Chowdhary, S. Purohit, and P. Parimoo, “Simultaneous determination of atenolol-amlodipine and haloperidol-trihexyphenidyl in combined tablet preparations by derivative spectroscopy,” Pharmacy and Pharmacology Communications, vol. 4, no. 7, pp. 325–330, 1998. View at Google Scholar · View at Scopus
  44. D. Bonazzi, R. Gotti, V. Andrisano, and V. Cavrini, “Derivative UV spectrophotometric determination of atenolol and metoprolol in single-and multi-component pharmaceutical dosage forms,” Farmaco, vol. 51, no. 11, pp. 733–738, 1996. View at Google Scholar · View at Scopus
  45. S. Singh and R. Jain, “Simultaneous spectrophotometric determination of atenolol and amlodipine besylate from dosage forms,” Indian Drugs, vol. 34, no. 11, pp. 678–679, 1997. View at Google Scholar · View at Scopus
  46. S. Wang, “Determination of atenolol in tablets by spectrophotometry,” Yaowu Fenxi Zazhi, vol. 10, no. 2, pp. 110–111, 1990. View at Google Scholar
  47. J. Huang and J. Jin, “Spectrophotometric determination of atenolol,” Zhongguo Yiyao Gongye Zazhi, vol. 20, no. 1, pp. 19–20, 1989. View at Google Scholar
  48. D. Satyanarayana, K. Kannan, and R. Manavalan, “Artificial neural network calibration models for simultaneous spectrophotometric determination of atenolol and losartan potassium in tablets,” Chemia Analityczna, vol. 51, no. 5, pp. 771–784, 2006. View at Google Scholar · View at Scopus
  49. W. Wehner, “Determination of atenolol and chlortalidone during dissolution of tablets with UV multicomponent analysis,” Die Pharmazie, vol. 55, no. 7, pp. 543–544, 2000. View at Google Scholar · View at Scopus
  50. M. C. F. Ferraro, P. M. Castellano, and T. S. Kaufman, “Chemometrics-assisted simultaneous determination of atenolol and chlorthalidone in synthetic binary mixtures and pharmaceutical dosage forms,” Analytical and Bioanalytical Chemistry, vol. 377, no. 7-8, pp. 1159–1164, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. K. Agrawal, K. Raman, S. Rajpu., and S. K. Menon, “Spectrophotometric determination of atenolol via hydroxamic acid formation,” Analytical Letters, vol. 25, no. 8, pp. 1503–1510, 1992. View at Google Scholar
  52. S. P. Agarwal, V. Singhal, and A. Prakash, “Spectrophotometric determination of atenolol and timolol dosage forms via charge-transfer complexation,” Indian Journal of Pharmaceutical Sciences, vol. 60, no. 1, pp. 53–55, 1998. View at Google Scholar · View at Scopus
  53. L. L. Yu, J. C. Liu, and H. K. Li, “Spectrophotometry determination of atenolol in tablets based on charge transfer complex of atenolol with chloranilic acid,” Yaowu Fenxi Zazhi, vol. 30, no. 3, pp. 538–540, 2010. View at Google Scholar
  54. M. A. Korany, M. H. Abdel-Hay, S. M. Galal, and M. A. Elsayed, “Colorimetric determination of some β-adrenergic blocking drugs in tablets,” Journal de Pharmacie de Belgique, vol. 40, no. 3, pp. 178–184, 1985. View at Google Scholar · View at Scopus
  55. S. M. Sultan, “Kinetic methods for the determination of anenolol in pharmaceutical preparations,” Acta Pharmaceutica Hungarica, vol. 62, no. 6, pp. 311–317, 1992. View at Google Scholar · View at Scopus
  56. S. M. Al-Ghannam and F. Belal, “Kinetic spectrophotometric determination of atenolol in dosage forms,” Journal of AOAC International, vol. 85, no. 4, pp. 817–823, 2002. View at Google Scholar · View at Scopus
  57. G. C. Hiremath, R. M. Mulla, and S. T. Nandibewoor, “Kinetic methods of determination of atenolol in pure compound and in pharmaceutical formulations,” Chemia Analityczna, vol. 50, no. 2, pp. 449–455, 2005. View at Google Scholar · View at Scopus
  58. N. Bashir, S. W. H. Shah, M. Bangesh, and R. Riazullah, “A novel spectrophotometric determination of atenolol using sodium nitroprusside,” Journal of Scientific and Industrial Research, vol. 70, no. 1, pp. 51–54, 2011. View at Google Scholar
  59. K. Basavaiah, U. Chandrashekar, and P. Nagegowda, “Determination of atenolol by spectrophotometry based on charge transfer complex formation reaction,” Acta Ciencia Indica Chemistry, vol. 30, no. 1, pp. 75–79, 2004. View at Google Scholar
  60. K. Basavaiah, U. Chandrashekar, and P. Nagegowda, “Sensitive determination of atenolol in tablets using chloramine-T and two dyes,” Indian Journal of Chemical Technology, vol. 11, no. 6, pp. 769–776, 2004. View at Google Scholar · View at Scopus
  61. K. Basavaiah, U. Chandrashekar, and P. Nagegowda, “Titrimetric, spectrophotometric and kinetic methods for the assay of atenolol using bromate-bromide and methyl orange,” Journal of the Serbian Chemical Society, vol. 71, no. 5, pp. 553–563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Basavaiah, U. Chandrashekar, B. C. Somashekar, and V. Ramakrishna, “Development and validation of neutralization reaction based on analytical methods for the assay of atenolol in pharmaceuticals,” Proceedings of the National Academy of Sciences of India A, vol. 75, no. 4, pp. 233–238, 2005. View at Google Scholar
  63. K. Basavaiah, “Application of bromate-bromide mixture and methyl orange in the titrimetric, spectrophotometric and kinetic assay methods for cyproheptadine in pharmaceuticals,” Indian Journal of Chemical Technology, vol. 13, no. 4, pp. 360–366, 2006. View at Google Scholar · View at Scopus
  64. A. M. El-Didamony and E. A. H. Erfan, “Utilization of oxidation reactions for the spectrophotometric determination of captopril using brominating agents,” Spectrochimica Acta Part A, vol. 75, no. 3, pp. 1138–1145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Basavaiah and U. R. Anilkumar, “Sensitive spectrophotometric methods for quantitative determination of gatifloxacin in pharmaceutical formulations using bromate-bromide, thiocyanate and tiron as reagents,” Journal of the Mexican Chemical Society, vol. 51, no. 2, pp. 106–112, 2007. View at Google Scholar
  66. K. Basavaiah and K. Tharpa, “Investigation and optimisation of the use of spectrophotometry for the assay of simvastatin with in situ bromine and three dyes as reagents,” Journal of the Mexican Chemical Society, vol. 52, no. 3, pp. 193–200, 2008. View at Google Scholar · View at Scopus
  67. ICH, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005.